BioLife Solutions, Inc. (NASDAQ:BLFS)’s share price hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $5.14 and last traded at $5.08, with a volume of 705,756 shares changing hands. The stock had previously closed at $4.85.
Several brokerages recently issued reports on BLFS. Maxim Group set a $6.00 price objective on shares of BioLife Solutions and gave the company a “buy” rating in a research note on Friday, August 11th. Janney Montgomery Scott raised shares of BioLife Solutions from a “neutral” rating to a “buy” rating and upped their price objective for the company from $2.62 to $5.00 in a research note on Wednesday, July 5th.
The firm has a 50-day moving average price of $4.31 and a 200-day moving average price of $2.82. The company’s market cap is $69.98 million.
BioLife Solutions (NASDAQ:BLFS) last released its earnings results on Thursday, August 10th. The medical equipment provider reported ($0.06) earnings per share for the quarter, hitting the consensus estimate of ($0.06). The business had revenue of $2.56 million for the quarter, compared to the consensus estimate of $2.40 million. BioLife Solutions had a negative net margin of 63.71% and a negative return on equity of 64.98%. On average, analysts expect that BioLife Solutions, Inc. will post ($0.24) EPS for the current year.
BioLife Solutions Company Profile
BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.
Receive News & Ratings for BioLife Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.